Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the CONFIRM study

Overview of attention for article published in Journal of Neurology, June 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

blogs: 1 blog

Citations

dimensions_citation: 57 Dimensions

Readers on

mendeley: 72 Mendeley

Summary Blogs Dimensions citations

So far, Altmetric has seen 2 posts from 1 blogs.

BG-12 influence on relapse

Multiple Sclerosis Research, 12 Jul 2013

Bar-Or A, Gold R, Kappos L, Arnold DL, Giovannoni G, Selmaj K, O'Gorman J, Stephan M, Dawson KT. Clinical efficacy of BG-12 (dime…

BG-12 Phase III Results: it is efficacious in subgroups of relapsing-remitting MS

Multiple Sclerosis Research, 18 Jun 2013

Despite BG-12 being effective in all subgroups of RRMSers European MSers must wait. For how long? #MSBlog #MSResearchEpub: Hutchi…